Release Date: 28/05/15 13:00 Summary: Investor Presentation - Hong Kong 28 May 2015 Price Sensitive: No Download Document 1.22MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%